Huang Junjie, Mak Fung-Yu, Wong Yuet-Yan, Ko Samantha, Chong Marc K C, Wang Zixin, Hon Kam-Lun, Wong Eliza L Y, Yeoh Eng-Kiong, Wong Martin C S
Jockey Club School of Public Health and Primary Care, Chinese University of Hong Kong, Hong Kong 999077, China.
School of Public Health, Peking Union Medical College, Beijing 100005, China.
Vaccines (Basel). 2022 Jul 21;10(7):1164. doi: 10.3390/vaccines10071164.
Invasive pneumococcal disease (IPD) is a leading cause of disability and mortality worldwide, particularly in the elderly population. With the implementation of the Government Vaccination Programme (GVP) and the Vaccination Subsidy Scheme (VSS), enabling factors and barriers in service provider scheme participation and vaccination uptake were examined in 32 interviews with doctors and 16 interviews with vaccine recipients. Interview data were analysed in NVivo 11.0 with reference to the Consolidated Framework for Implementation Research (CFIR) and the REAIM Framework to develop codes and themes. Barriers to pneumococcal vaccination uptake included concerns on vaccine efficacy and poor understanding of the disease and vaccine schemes, whilst service provider participation was hindered by ill-defined parameters for patient eligibility and time, location, and logistical constraints. Enabling factors to improve intervention implementation were involvement of the government and physicians to encourage participation, clarifying eligibility criteria, and improving individual knowledge of IPD and vaccination schemes. As participation rates in the GVP and VSS remains low in Hong Kong, efforts concentrating on health promotion strategies encouraging pneumococcal vaccination amongst the elderly population are recommended.
侵袭性肺炎球菌疾病(IPD)是全球残疾和死亡的主要原因,在老年人群中尤为如此。随着政府疫苗接种计划(GVP)和疫苗接种补贴计划(VSS)的实施,通过对32名医生的访谈和16名疫苗接种者的访谈,研究了服务提供者参与计划和疫苗接种的促进因素及障碍。访谈数据在NVivo 11.0中参照实施研究综合框架(CFIR)和REAIM框架进行分析,以制定编码和主题。肺炎球菌疫苗接种的障碍包括对疫苗效力的担忧以及对疾病和疫苗计划的了解不足,而服务提供者的参与则受到患者资格参数不明确以及时间、地点和后勤限制的阻碍。改善干预措施实施的促进因素包括政府和医生鼓励参与、明确资格标准以及提高个人对IPD和疫苗接种计划的认识。由于香港GVP和VSS的参与率仍然较低,建议集中精力采取健康促进策略,鼓励老年人群接种肺炎球菌疫苗。